Atomo Diagnostics Limited (ASX:AT1)
0.0200
0.00 (0.00%)
Aug 18, 2025, 4:10 PM AEST
Atomo Diagnostics Revenue
Atomo Diagnostics had revenue of 2.05M AUD in the half year ending December 31, 2024, with 51.03% growth. This brings the company's revenue in the last twelve months to 4.22M, up 35.63% year-over-year. In the fiscal year ending June 30, 2024, Atomo Diagnostics had annual revenue of 4.09M with 60.65% growth.
Revenue (ttm)
4.22M
Revenue Growth
+35.63%
P/S Ratio
3.84
Revenue / Employee
49.60K
Employees
85
Market Cap
16.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.09M | 1.54M | 60.65% |
Jun 30, 2023 | 2.54M | -9.79M | -79.38% |
Jun 30, 2022 | 12.34M | 5.62M | 83.69% |
Jun 30, 2021 | 6.72M | 1.35M | 25.09% |
Jun 30, 2020 | 5.37M | 4.83M | 894.69% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |